 WIXOM, Mich. , April 20, 2022 PRNewswire -- Rockwell Medical, Inc. Nasdaq: RMTI Rockwell Medical or the Company, a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients, today announced that the company is scheduled to present at the Noblecon18, Noble Capital Markets 18th Annual Investor Conference in Hollywood, Florida, on Thursday, April 21 st at 10:00 AM ET. 